Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Healthcare, Regulatory and Reimbursement Landscape - Jordan
1. Healthcare, Regulatory and Reimbursement Landscape - Jordan
Report Details:
Published:January 2013
No. of Pages: 133
Price: Single User License – US$1995
Healthcare, Regulatory and Reimbursement Landscape - Jordan
Summary
GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory
and Reimbursement Landscape - Jordan”. The report is an essential source of information and
provides an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. The
report identifies the key trends in the healthcare market of Jordan. The report also provides
insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure
of Jordan. Most importantly, the report provides valuable insights on the trends and segmentation
of the pharmaceutical market. This report is built using data and information sourced from
proprietary databases, secondary research and in-house analysis by GlobalData’s team of
industry experts.
Jordan has a small population, approximately 6.2 million in 2011. However, the population of
Jordan is increasing due to a high birth rate and low mortality rate, along with an increase in life
expectancy. The increase in the population of the working-age sector of the population will support
the country’s development, but the country’s high unemployment rate is a cause of concern for
policy planners. The pharmaceutical market in Jordan was estimated at $487.6m in 2011 and is
expected to reach approximately $1,112.1m by 2020, at a projected Compound Annual Growth
Rate (CAGR) of 9.6% between 2012 and 2020.
The positive trend in the healthcare market of Jordan can be attributed primarily to -
- Increase in exports of pharmaceutical products
- High share of public health insurance
- Increasing access to healthcare facilities
- Government initives in healthcare sector
- Increasing affordabilty
Scope
2. The report provides information on the healthcare, regulatory and reimbursement landscape of
Jordan. The scope includes -
- An overview of the pharmaceutical market of Jordan including the market size, market
segmentation, key drivers and barriers for the market.
- Profiles and SWOT analyses of the major players in the pharmaceutical market. Key players
covered for the pharmaceutical market are Hikma Pharmaceuticals, Dar al Dawa Development &
Investment, Jordan Pharmaceutical Manufacturing and Pharma International.
- An insightful review of the reimbursement and regulatory landscape. The analysis includes
details of the healthcare reimbursement process, regulatory agencies and marketing authorization
process for new drugs in Jordan.
- A detailed analysis of the political and economic environment of Jordan, including the economic
indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of
Jordan.
Reasons to buy
The report comprehensively covers pharmaceutical market of Jordan, and will enhance your
decision-making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare
market of Jordan.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical market segments and companies likely to impact the Jordanian healthcare market
in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape
and by analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market
of Jordan.
Get your copy of this report @
http://www.reportsnreports.com/reports/213161-healthcare-regulatory-and-reimbursement-landscape-jordan.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 Report Guidance 9
3 Overview of the Pharmaceutical and Medical Devices Market 10
3.1 Pharmaceutical Market 10
3. 3.1.1 Market Overview 10
3.1.2 Supply Channels 13
3.1.3 Market Segments 14
3.1.4 Major Disease Areas 17
3.1.5 Major Players 18
3.2 Medical Device Market 34
3.2.1 Market Overview 34
3.3 Market Drivers and Barriers 35
3.3.1 Drivers 35
3.3.2 Barriers 36
4 Market Access 38
4.1 Reimbursement and Payer Landscape 38
4.1.1 Healthcare System Overview 38
4.1.2 Reimbursement Process 38
4.1.3 Overview of Insurance Providers 41
4.1.4 Patients Share in Healthcare Spending 42
4.1.5 Price Trend in Healthcare Services 43
4.1.6 Pricing Policies 43
4.2 Regulatory Landscape 45
4.2.1 Overview of Regulatory Agencies 45
4.2.2 Marketing Authorization Procedure for Pharmaceutical Products 45
4.2.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing 47
4.2.4 Licensing Process for Pharmaceutical Exports and Imports 49
4.2.5 Intellectual Property Rights 50
4.2.6 Clinical Trial Regulations 55
4.2.7 Pharmaceutical Advertising Regulations 55
4.2.8 Pharmacy Regulations 56
4.2.9 Labeling and Packaging Regulations 56
5 Country Analysis 58
5.1 Political Environment 58
5.1.1 Political Structure 58
5.1.2 Analysis of the Current Political Environment 59
5.1.3 Healthcare Policy Initiatives 60
5.2 Economic Landscape 61
5.3 Economic Indicators 63
5.3.1 Gross Domestic Product 63
5.3.2 Gross National Income 67
5.3.3 Inflation 68
5.3.4 Currency Exchange Rate 71
5.3.5 Foreign Direct Investment 72
5.3.6 Foreign Exchange Reserves 73
5.3.7 Trade Balance 74
4. 5.3.8 Government Net Debt 76
5.3.9 Government Structural Balance 78
5.3.10 Major Industries 80
5.4 Demography 81
5.4.1 Population 81
5.4.2 Education and Literacy 96
5.4.3 Employment 98
5.4.4 Disease Burden 100
5.5 Healthcare Infrastructure 101
5.5.1 Healthcare Facilities 101
5.5.2 Healthcare Parameters 108
5.5.3 Environmental Health 110
5.5.4 Healthcare Personnel 116
5.6 Healthcare Expenditure 117
5.6.1 Overview 117
5.6.2 Major Components of Healthcare Spending 118
5.6.3 Share of Public and Private Sectors 119
5.6.4 Spending in Healthcare R&D 119
5.7 Trade Associations 119
5.7.1 Jordanian Association of Pharmaceutical Manufacturers 119
5.7.2 Jordan Pharmacist Association 119
6 Opportunities and Challenges 120
6.1 Opportunities 120
6.2 Challenges 121
7 Appendix 123
7.1 Abbreviations 123
7.2 Bibliography 124
7.3 Methodology 131
7.3.1 Coverage 131
7.3.2 Secondary Research 132
7.3.3 Forecasting 132
7.3.4 Primary Research 132
7.3.5 Expert Panel Validation 132
7.4 Contact Us 133
7.5 Disclaimer 133
1.1 List of Tables
Table 1: Pharmaceutical Market, Jordan, Revenue ($m), 2006-2011 11
Table 2: Pharmaceutical Market, Jordan, Forecast ($m), 2012-2020 12
Table 3: Drugs Going Off-patent, Revenues ($bn), Global, 2011-2015 15
Table 4: Major Products, Hikma Pharmaceuticals PLC, 2012 18
Table 5: Major Products, Dar Al Dawa Development & Investment Co. Ltd, Jordan, 2012 22
5. Table 6: Major Products, Jordanian Pharmaceutical Manufacturing Co. Plc, Jordan, 2012 27
Table 7: Major Products, Pharma International Co, 2012 32
Table 8: Healthcare Spending, Jordan, Patient''s Share (%), 2005-2010 42
Table 9: Price Trend in Healthcare Sector (%), Jordan, 2005-2010 43
Table 10: GDP Per Capita ($), Jordan, 2006-2011 63
Table 11: GDP Per Capita ($), Jordan, Forecast, 2012-2020 64
Table 12: GDP, Jordan, Annual Growth (%), 2006-2011 65
Table 13: GDP, Jordan, Annual Growth (%), Forecast, 2012-2020 66
Table 14: GNI Per Capita ($), Jordan, 2006-2011 67
Table 15: Average Consumer Price Index, Jordan, 2006-2011 68
Table 16: Average Consumer Price Index, Jordan, Forecast, 2012-2020 69
Table 17: Average Consumer Price, Jordan, Annual Change (%), 2006-2011 70
Table 18: Average Consumer Price, Jordan, Annual Change (%), Forecast, 2012-2020 70
Table 19: Currency Exchange Rate ($/JOD), Jordan, 2006-2011 71
Table 20: Foreign Direct Investment ($bn), Jordan, 2005-2010 72
Table 21: Foreign Exchange Reserves ($bn), Jordan, 2006-2011 73
Table 22: Imports of Goods and Services ($bn), Jordan, 2006-2011 74
Table 23: Exports of Goods and Services ($bn), Jordan, 2006-2011 75
Table 24: General Government Net Debt ($bn), Jordan, 2006-2011 76
Table 25: General Government Net Debt ($bn), Jordan, Forecast, 2012-2020 77
Table 26: General Government Structural Balance ($bn), Jordan, 2006-2011 78
Table 27: General Government Structural Balance ($bn), Jordan, Forecast, 2012-2020 79
Table 28: Major Industries, Jordan, GDP ($bn), 2011 80
Table 29: Population (m), Jordan, 2006-2011 81
Table 30: Population (m), Jordan, Forecast, 2012-2020 82
Table 31: Urban and Rural Population, Jordan, Share (%), 2006-2011 83
Table 32: Age Groups, Jordan, Population Distribution (%), 2006-2011 84
Table 33: Age Groups, Jordan, Population Distribution (%), Forecast, 2012-2020 85
Table 34: Births (Per 1,000 Population), Jordan, 2006-2011 86
Table 35: Mortality (Per 1,000 Population), Jordan, 2006-2011 87
Table 36: Major Causes of Mortality (‘000s), Jordan, 2008 88
Table 37: Children Table 38: Maternal Mortality (Per 100,000 Live Births), Jordan, 2006-2011 90
Table 39: Immunization Rate (%), Jordan, 2006-2011 91
Table 40: Major Causes of Male Mortality (‘000s), Jordan, 2008 92
Table 41: Major Causes of Female Mortality (‘000s), Jordan, 2008 93
Table 42: Gender Ratio (Male Per 100 Female Population), Jordan, 2006-2011 94
Table 43: Life Expectancy at Birth (Years), Jordan, 2006-2011 95
Table 44: Illiteracy Rate, Jordan, Population (%), 2006-2011 96
Table 45: Levels of Education, Jordan, Students Share (%), 2006-2011 97
Table 46: Unemployment Rate (%), Jordan, 2006-2011 98
Table 47: Employees, Jordan, Segment Share (%), 2011 99
Table 48: Major Diseases, Jordan, DALY (Per 100,000 Population), 2004 100